Cafcit and Drug maladministration - a phase IV clinical study of FDA data

Summary:

Drug maladministration is reported as a side effect among people who take Cafcit (caffeine citrate), especially for people who are female, 0-1 old,.

The phase IV clinical study analyzes which people have Drug maladministration when taking Cafcit. It is created by eHealthMe based on reports of 65 people who have side effects when taking Cafcit from the FDA, and is updated regularly.

What is Cafcit?

Cafcit has active ingredients of caffeine citrate. eHealthMe is studying from 65 Cafcit users. Check the latest studies of Cafcit.

What is Drug maladministration?

Drug maladministration is found to be associated with 553 drugs and 1 condition by eHealthMe. Check the latest studies of Drug maladministration.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

65 people reported to have side effects when taking Cafcit.
Among them, 18 people (27.69%) have Drug maladministration.

Could Cafcit cause Drug maladministration?

Among these 18 people:

What is the gender of people who have Drug maladministration when taking Cafcit? *

female: 100 %
male: 0.0 %

What is the age of people who have Drug maladministration when taking Cafcit? *

What are other side effects people have besides Drug maladministration? *

Sweating Increased (excess sweating): 2 people, 11.11%
Irritability: 2 people, 11.11%
Feeling Jittery: 2 people, 11.11%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 2 people, 11.11%
Injection Site Necrosis (death of body tissue at injection site): 2 people, 11.11%
Injection Site Extravasation (flow of (blood or lymph) from injection site): 2 people, 11.11%
Respiratory Distress Syndrome (Rds) In Infants (respiratory disease of newborn babies, especially premature babies, characterized by distressful breathing, cyanosis, and the formation of a glassy membrane over the alveoli of the lungs): 2 people, 11.11%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 2 people, 11.11%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 5.56%
Neonatal Apnoeic Attack (episodes where breathing stops temporarily in neonate): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Cafcit and have Drug maladministration?

- Check whether Drug maladministration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cafcit:

Cafcit (65 reports)

Browse all side effects of Cafcit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug maladministration:

Drug maladministration (553 drugs)

Browse all the conditions that are associated with Drug maladministration:

Drug maladministration (1 condition)

How the study uses the data?

The study uses data from the FDA. It is based on caffeine citrate (the active ingredients of Cafcit) and Cafcit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.